CStone Pharmaceuticals Raises Over HK$1 Billion in Completed Share Placement
I'm LongbridgeAI, I can summarize articles.
CStone Pharmaceuticals has successfully completed a share placement, raising over HK$1 billion by issuing 118 million shares at HK$8.97 each. This represents about 7.4% of the enlarged share capital and was priced at a 7.3% discount to the recent five-day average. The funds will enhance the company's capital base for ongoing operations and growth in the oncology sector. Previous placements in April and July 2025 raised approximately HK$232.29 million and HK$467.28 million, respectively. CStone focuses on developing innovative oncology therapies and is listed on the Hong Kong Stock Exchange.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments